Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 66

Sort by

Sort Order Select

Journal Articles

Poor Prognosis in Children with ABL -Class Fusion Positive B-Cell Acute Lymphoblastic Leukemia Treated According to AIEOP-BFM Protocols

Blood (2019) 134 (Supplement_1): 1351.

https://doi.org/10.1182/blood-2019-126523

Published: 2019

Journal Articles

Transient Switch to Myeloid Lineage in Acute Lymphoblastic Leukemia during Induction Therapy: The Role of CD371 Expression and Implication for Minimal Residual Disease Detection

Elena Varotto, MD PhD, Margarita Maurer-Granofszky, PhD, Daniela Silvestri, Pamela Scarparo, PhD, Ester Mejstrikova, MD PhD, Monika Brüggemann, Giovanni Cazzaniga, PhD, Valentino Conter, MD, Ondrej Hrusak, MD PhD, Giuseppe Gaipa, PhD, Angela Schumich, Maria Grazia Valsecchi, PhD, Giuseppe Basso, MD PhD, Michael Dworzak, MD, Barbara Buldini, MD PhD

Blood (2019) 134 (Supplement_1): 377.

https://doi.org/10.1182/blood-2019-127287

Published: 2019

Journal Articles

Long-Term Outcome of Relapsed Acute T-Lymphoblastic Leukemia (T-ALL) in Children and Adolescents

Luciana Vinti, MD, Luisa Strocchio, MD, Barbara Buldini, MD PhD, Daniela Silvestri, Valentino Conter, MD, Pietro Merli, MD, Carmelo Rizzari, Rosanna Parasole, MD, Maddalena Paganin, PhD, Giuseppe Basso, MD PhD, Marco Zecca, Franco Locatelli, MD PhD

Blood (2019) 134 (Supplement_1): 2580.

https://doi.org/10.1182/blood-2019-131292

Published: 2019

Journal Articles

Prognostic Value of Minimal Residual Disease Measured By Flow Cytometry in Two Cohorts of Infants with Acute Lymphoblastic Leukemia Treated with MLL-Baby and Interfant Protocols in Large Multicenter Networks

Blood (2019) 134 (Supplement_1): 2747.

https://doi.org/10.1182/blood-2019-130210

Published: 2019

Journal Articles

Digital-Droplet PCR, an Accurate Method for IG/TR PCR-MRD Stratification in Childhood Acute Lymphoblastic Leukemia

Irene Della Starza, PhD, Vittorio Nunes, Federica Lovisa, Daniela Silvestri, Marzia Cavalli, PhD, Andrea Garofalo, Mimma Campeggio, Lucia Anna De Novi, PhD, Carlotta Oggioni, Andrea Biondi, MD, Anna Guarini, PhD, Maria Grazia Valsecchi, PhD, Valentino Conter, MD, Giuseppe Basso, MD, Robin Foà, MD, Giovanni Cazzaniga, PhD

Blood (2018) 132 (Supplement 1): 1544.

https://doi.org/10.1182/blood-2018-99-117954

Published: 2018

Journal Articles

Clonal Evolution Mechanisms and Collateral Sensitivity to Impdh Inhibitor Therapy in Relapsed Lymphoblastic Leukemia

Chelsea Dieck, Gannie Tzoneva, PhD, Koichi Oshima, MD PhD, Alberto Ambesi-Impiombato, Marta Sanchez-Martin, PhD, Maria Luisa Sulis, MD, Motohiro Kato, MD PhD, Katsuyoshi Koh, MD, Maddalena Paganin, PhD, Giuseppe Basso, MD, Julie M. Gastier-Foster, PhD, Mignon L. Loh, MD, Renate Kirschner-Schwabe, PhD, Chioma Madubata, Raul Rabadan, Adolfo A. Ferrando, MD PhD

Blood (2017) 130 (Supplement 1): 2602.

https://doi.org/10.1182/blood.V130.Suppl_1.2602.2602

Published: 2017

Journal Articles

Long Non Coding RNA BALR2-CDK6 Axis Influences Cell Differentiation and Metabolic Status of Acute Myeloid Leukemia

Valeria Bisio, PhD, Claudia Tregnago, PhD, Matteo Zampini, PhD, Giulia Borella, PhDstudent, Thilini Fernando, Dinesh S. Rao, MD PhD, Andrea Pession, MD, Franco Locatelli, MD PhD, Giuseppe Basso, MD, Pigazzi Martina, PhD

Blood (2017) 130 (Supplement 1): 3935.

https://doi.org/10.1182/blood.V130.Suppl_1.3935.3935

Published: 2017

Journal Articles

Rhob Overexpression Boosts Relapse of t(8;21) RUNX1-RUNX1T1 Rearranged Acute Myeloid Leukemia.

Pigazzi Martina, PhD, Zampini Matteo, PhD, Claudia Tregnago, PhD, Valeria Bisio, PhD, Luca Simula, PhD, Giulia Borella, PhDstudent, Carlo Zanon, PhD, Valentina Serafin, PhD, Benedetta Accordi, PhD, Silvia Campello, PhD, Barbara Buldini, MD PhD, Andrea Pession, MD, Franco Locatelli, MD PhD, Giuseppe Basso, MD

Blood (2017) 130 (Supplement 1): 1192.

https://doi.org/10.1182/blood.V130.Suppl_1.1192.1192

Published: 2017

Journal Articles

Elevated Level Expression of MiR-223 Is Associated with Worse Prognosis in Childhood T-Cell Lymphoblastic Lymphoma

Lara Mussolin, PhD, Elena Pomari, PhD, Marta Pillon, MD, Federica Lovisa, PhD, Elisa Carraro, PhD, Paolo Bonvini, PhD, Emanuele SG d'Amore, MD, Giuseppe Basso, MD

Blood (2016) 128 (22): 1098.

https://doi.org/10.1182/blood.V128.22.1098.1098

Published: 2016

Journal Articles

Mutational Landscape, Clonal Evolution Patterns and Role of RAS Mutations in Relapsed Acute Lymphoblastic Leukemia

Blood (2016) 128 (22): 4068.

https://doi.org/10.1182/blood.V128.22.4068.4068

Published: 2016

Journal Articles

Evaluation of Minimal Residual Disease As a Surrogate Endpoint for Event Free Survival in Childhood B-Lineage Acute Lymphoblastic Leukemia

Maria Grazia Valsecchi, PhD, Meenakshi Devidas, PhD, Ausiliatrice Lucenti, PhD, Martin Schrappe, MD, Giovanni Cazzaniga, PhD, Anja Moricke, MD, Claus R. Bartram, PhD, Georg Mann, MD, William L. Carroll, MD, Eric Larsen, MD, Naomi Winick, MD, Giuseppe Basso, MD, Valentino Conter, Martin Zimmermann, PhD, Stefan Sushu, Andrea Biondi, MD, Stephen Hunger, MD, Stefania Galimberti, PhD

Blood (2016) 128 (22): 759.

https://doi.org/10.1182/blood.V128.22.759.759

Published: 2016

Journal Articles

Validation of MRD Quantification By Flow Cytometry for Pediatric BCP ALL Relapsed Patients Treated on the Intreall Protocol

Blood (2015) 126 (23): 1414.

https://doi.org/10.1182/blood.V126.23.1414.1414

Published: 2015

Journal Articles

Prognostic Role of Minimal Residual Disease before and after Hematopoietic Stem Cell Transplantation in Childhood Acute Lymphoblastic Leukemia

Bartolomeo Rossi, MD, Mimma Campeggio, Elisa Magrin, PhD, Marco Zecca, MD, Laura Rubert, MD, Franca Fagioli, MD, Paola Quarello, MD, Federica Lovisa, PhD, Giuseppe Basso, MD

Blood (2015) 126 (23): 1413.

https://doi.org/10.1182/blood.V126.23.1413.1413

Published: 2015

Journal Articles

Three Dimensional Speckle Tracking Echocardiography (3D-STE) for Early Detection of Subtle Myocardial Deformation Dysfunction in Thalassemic Patients

Blood (2015) 126 (23): 2158.

https://doi.org/10.1182/blood.V126.23.2158.2158

Published: 2015

Journal Articles

FOXM1 Is Overexpressed in B-Acute Lymphoblastic Leukemia (B-All) and Its Inhibition Sensitizes B-All Cells to Chemotherapeutic Drugs

Francesca Consolaro, MS, Giuseppe Basso, MD, Giampietro Viola, PhD, Eric W-.F. Lam, PhD

Blood (2014) 124 (21): 2245.

https://doi.org/10.1182/blood.V124.21.2245.2245

Published: 2014

Journal Articles

Results of an AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Randomized Clinical Trial in Children with Low- and Intermediate-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

Franco Locatelli, Marco Zecca, MD, Gianni Cazzaniga, PhD, Luciana Vinti, MD, Andrea Biondi, Tommaso Mina, MD, Chiara Messina, Rosanna Parasole, Franca Fagioli, MD, Ottavio Ziino, Giuseppe Basso, MD, Riccardo Masetti, MD, Carmelo Rizzari

Blood (2014) 124 (21): 65.

https://doi.org/10.1182/blood.V124.21.65.65

Published: 2014

Journal Articles

NUP98 Fusion Proteins Are Recurrent Aberrancies in Childhood Acute Myeloid Leukemia: A Report from the AIEOP AML-2001-02 Study Group

Valeria Bisio, BS, Martina Pigazzi, PhD, Elena Manara, PhD, Riccardo Masetti, MD, Marco Togni, BS, Annalisa Astolfi, PhD, Cristina Mecucci, MD PhD, Vincenzo Zappavigna, PhD, Valentina Salsi, PhD, Pietro Merli, MD, Carmelo Rizzari, Franca Fagioli, MD, Franco Locatelli, Giuseppe Basso, MD

Blood (2014) 124 (21): 1025.

https://doi.org/10.1182/blood.V124.21.1025.1025

Published: 2014

Journal Articles

The Strong Prognostic Effect of Concurrent Deletions of IKZF1 and PAX5 , CDKN2A , CDKN2B or PAR1 in the Absence of ERG Deletions (IKZF1 plus ) in Pediatric Acute Lymphoblastic Leukemia Strongly Depends on Minimal Residual Disease Burden after Induction Treatment

Blood (2014) 124 (21): 131.

https://doi.org/10.1182/blood.V124.21.131.131

Published: 2014

Journal Articles

Subunit a of Coagulation Factor XIII As a New Biomarker in Childhood Acute Lymphoblastic Leukemia?

Csongor Kiss, MD PhD DSc, Katalin Gyurina, László Csáthy, MD, Silvia Bresolin, PhD, Geertruy te Kronnie, PhD, Zsuzsa Hevessy, MD PhD, István Szegedi, MD PhD, Beáta Scholtz, PhD, János Kappelmayer, MD PhD DSc, Giuseppe Basso, MD

Blood (2014) 124 (21): 5346.

https://doi.org/10.1182/blood.V124.21.5346.5346

Published: 2014

Journal Articles

Refinement of IKZF1 Genomic Status in Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Tobia Lana, Paola de Lorenzo, Silvia Bresolin, PhD, Ilaria Bronzini, Monique L. Den Boer, MSc, PhD, Helene Cave, PhD, Eva Fronkova, MD, PhD, Martin Stanulla, MD, Marketa Zaliova, Christine J. Harrison, Hester de Groot-Kruseman, Claire Schwab, Maria Grazia Valsecchi, Andrea Biondi, Giuseppe Basso, MD, Giovanni Cazzaniga, PhD, Geertruy te Kronnie

Blood (2014) 124 (21): 3785.

https://doi.org/10.1182/blood.V124.21.3785.3785

Published: 2014

NARROW

Poor Prognosis in Children with ABL -Class Fusion Positive B-Cell Acute Lymphoblastic Leukemia Treated According to AIEOP-BFM Protocols

Transient Switch to Myeloid Lineage in Acute Lymphoblastic Leukemia during Induction Therapy: The Role of CD371 Expression and Implication for Minimal Residual Disease Detection

Long-Term Outcome of Relapsed Acute T-Lymphoblastic Leukemia (T-ALL) in Children and Adolescents

Prognostic Value of Minimal Residual Disease Measured By Flow Cytometry in Two Cohorts of Infants with Acute Lymphoblastic Leukemia Treated with MLL-Baby and Interfant Protocols in Large Multicenter Networks

Digital-Droplet PCR, an Accurate Method for IG/TR PCR-MRD Stratification in Childhood Acute Lymphoblastic Leukemia

Clonal Evolution Mechanisms and Collateral Sensitivity to Impdh Inhibitor Therapy in Relapsed Lymphoblastic Leukemia

Long Non Coding RNA BALR2-CDK6 Axis Influences Cell Differentiation and Metabolic Status of Acute Myeloid Leukemia

Rhob Overexpression Boosts Relapse of t(8;21) RUNX1-RUNX1T1 Rearranged Acute Myeloid Leukemia.

Elevated Level Expression of MiR-223 Is Associated with Worse Prognosis in Childhood T-Cell Lymphoblastic Lymphoma

Mutational Landscape, Clonal Evolution Patterns and Role of RAS Mutations in Relapsed Acute Lymphoblastic Leukemia

Evaluation of Minimal Residual Disease As a Surrogate Endpoint for Event Free Survival in Childhood B-Lineage Acute Lymphoblastic Leukemia

Validation of MRD Quantification By Flow Cytometry for Pediatric BCP ALL Relapsed Patients Treated on the Intreall Protocol

Prognostic Role of Minimal Residual Disease before and after Hematopoietic Stem Cell Transplantation in Childhood Acute Lymphoblastic Leukemia

Three Dimensional Speckle Tracking Echocardiography (3D-STE) for Early Detection of Subtle Myocardial Deformation Dysfunction in Thalassemic Patients

FOXM1 Is Overexpressed in B-Acute Lymphoblastic Leukemia (B-All) and Its Inhibition Sensitizes B-All Cells to Chemotherapeutic Drugs

Results of an AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Randomized Clinical Trial in Children with Low- and Intermediate-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

NUP98 Fusion Proteins Are Recurrent Aberrancies in Childhood Acute Myeloid Leukemia: A Report from the AIEOP AML-2001-02 Study Group

The Strong Prognostic Effect of Concurrent Deletions of IKZF1 and PAX5 , CDKN2A , CDKN2B or PAR1 in the Absence of ERG Deletions (IKZF1 plus ) in Pediatric Acute Lymphoblastic Leukemia Strongly Depends on Minimal Residual Disease Burden after Induction Treatment

Subunit a of Coagulation Factor XIII As a New Biomarker in Childhood Acute Lymphoblastic Leukemia?

Refinement of IKZF1 Genomic Status in Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only